Suparma（SPMA）株式概要PT Suparma Tbk はインドネシアで紙および関連紙製品の製造・販売を行っている。 詳細SPMA ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績4/6財務の健全性6/6配当金0/6報酬当社が推定した公正価値より82.1%で取引されている 過去1年間で収益は8.2%増加しました リスク分析過去5年間で収益は年間23.6%減少しました。 意味のある時価総額がありません ( IDR869B )すべてのリスクチェックを見るSPMA Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueRpCurrent PriceRp210.00106.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture03t2016201920222025202620282031Revenue Rp2.8tEarnings Rp105.2bAdvancedSet Fair ValueView all narrativesPT Suparma Tbk 競合他社Pabrik Kertas Tjiwi KimiaSymbol: IDX:TKIMMarket cap: Rp17.4tIndah Kiat Pulp & PaperSymbol: IDX:INKPMarket cap: Rp42.9tAsia PramuliaSymbol: IDX:ASPRMarket cap: Rp667.2bGunawan Dianjaya SteelSymbol: IDX:GDSTMarket cap: Rp841.1b価格と性能株価の高値、安値、推移の概要Suparma過去の株価現在の株価Rp210.0052週高値Rp338.4652週安値Rp190.77ベータ0.591ヶ月の変化-0.94%3ヶ月変化-11.76%1年変化1.11%3年間の変化-41.91%5年間の変化-33.24%IPOからの変化206.56%最新ニュースお知らせ • May 23PT Suparma Tbk, Annual General Meeting, Jun 30, 2026PT Suparma Tbk, Annual General Meeting, Jun 30, 2026.Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.最新情報をもっと見るRecent updatesお知らせ • May 23PT Suparma Tbk, Annual General Meeting, Jun 30, 2026PT Suparma Tbk, Annual General Meeting, Jun 30, 2026.Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023)Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Reported Earnings • Jul 31Second quarter 2024 earnings released: EPS: Rp8.89 (vs Rp12.20 in 2Q 2023)Second quarter 2024 results: EPS: Rp8.89 (down from Rp12.20 in 2Q 2023). Revenue: Rp618.2b (up 2.5% from 2Q 2023). Net income: Rp26.4b (down 31% from 2Q 2023). Profit margin: 4.3% (down from 6.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.New Risk • Jul 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.6% net profit margin). Market cap is less than US$100m (Rp908.4b market cap, or US$55.4m).お知らせ • May 09PT Suparma Tbk, Annual General Meeting, Jun 14, 2024PT Suparma Tbk, Annual General Meeting, Jun 14, 2024. Location: Vasa Hotel Surabaya Jawa Timur IndonesiaReported Earnings • May 04First quarter 2024 earnings released: EPS: Rp7.00 (vs Rp25.65 in 1Q 2023)First quarter 2024 results: EPS: Rp7.00 (down from Rp25.65 in 1Q 2023). Revenue: Rp657.6b (down 5.9% from 1Q 2023). Net income: Rp22.6b (down 72% from 1Q 2023). Profit margin: 3.4% (down from 12% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 7% per year.New Risk • Apr 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.7% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.7% net profit margin). Market cap is less than US$100m (Rp1.09t market cap, or US$68.4m).Reported Earnings • Apr 03Full year 2023 earnings released: EPS: Rp57.00 (vs Rp107 in FY 2022)Full year 2023 results: EPS: Rp57.00 (down from Rp107 in FY 2022). Revenue: Rp2.66t (down 15% from FY 2022). Net income: Rp178.7b (down 47% from FY 2022). Profit margin: 6.7% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year.Valuation Update With 7 Day Price Move • Oct 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to Rp338, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 4x in the Forestry industry in Indonesia. Total returns to shareholders of 85% over the past three years.Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: Rp12.30 (vs Rp10.32 in 2Q 2022)Second quarter 2023 results: EPS: Rp12.30 (up from Rp10.32 in 2Q 2022). Revenue: Rp603.0b (down 23% from 2Q 2022). Net income: Rp38.5b (up 4.8% from 2Q 2022). Profit margin: 6.4% (up from 4.7% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 19PT Suparma Tbk, Annual General Meeting, Jun 08, 2023PT Suparma Tbk, Annual General Meeting, Jun 08, 2023, at 03:00 Coordinated Universal Time. Location: Meeting Room of PT Suparma Tbk Jl. Mastrip No. 856 Surabaya Indonesia Agenda: To consider the approval on the company's annual report including the company's audited financial statements and the board of commissioners' Supervisory Duty Report for financial year ended on December 31, 2022; to consider to determine the use of the company's net profit for the financial year ended on December 31, 2022; to consider to appoint the Registered Public Accountant and/or Registered Public Accounting Firm that will Audit the company's financial statements for the financial year ended on December 31, 2023; and to transact such other business issues.Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Corporate Secretary & Independent Director Hendro Luhur is the most experienced director on the board, commencing their role in 1998. Independent Commissioner M. Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Nov 06Third quarter 2022 earnings released: EPS: Rp54.76 (vs Rp72.09 in 3Q 2021)Third quarter 2022 results: EPS: Rp54.76. Revenue: Rp814.9b (up 15% from 3Q 2021). Net income: Rp130.9b (up 12% from 3Q 2021). Profit margin: 16% (in line with 3Q 2021).Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp555, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 15x in the Forestry industry in Indonesia. Total returns to shareholders of 145% over the past three years.Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp755, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 19x in the Forestry industry in Indonesia. Total returns to shareholders of 266% over the past three years.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Commissioner Tan Juanto was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp815, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 325% over the past three years.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp685, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 247% over the past three years.Valuation Update With 7 Day Price Move • Nov 24Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp585, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 213% over the past three years.Reported Earnings • Nov 07Third quarter 2021 earnings released: EPS Rp79.47 (vs Rp7.85 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp710.0b (up 30% from 3Q 2020). Net income: Rp117.1b (up 435% from 3Q 2020). Profit margin: 17% (up from 4.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to Rp422, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 131% over the past three years.Reported Earnings • Jul 30Second quarter 2021 earnings released: EPS Rp24.89 (vs Rp30.91 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: Rp616.9b (up 43% from 2Q 2020). Net income: Rp37.7b (down 56% from 2Q 2020). Profit margin: 6.1% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 27% per year.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp390, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 112% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp610, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 123% over the past three years.Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to Rp520, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 12x in the Forestry industry in Indonesia. Total returns to shareholders of 82% over the past three years.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp370, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 24% over the past three years.Is New 90 Day High Low • Feb 26New 90-day high: Rp336The company is up 3.0% from its price of Rp326 on 27 November 2020. The Indonesian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 62% over the same period.Is New 90 Day High Low • Jan 28New 90-day low: Rp276The company is down 1.0% from its price of Rp280 on 27 October 2020. The Indonesian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 61% over the same period.Is New 90 Day High Low • Nov 11New 90-day high: Rp296The company is up 15% from its price of Rp258 on 13 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 1.0% over the same period.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of Rp118.1b, down 19% from the prior year. Total revenue was Rp2.18t over the last 12 months, down 15% from the prior year.株主還元SPMAID ForestryID 市場7D1.9%-13.3%-7.4%1Y1.1%11.9%-17.9%株主還元を見る業界別リターン: SPMA過去 1 年間で11.9 % の収益を上げたID Forestry業界を下回りました。リターン対市場: SPMA過去 1 年間で-17.9 % の収益を上げたID市場を上回りました。価格変動Is SPMA's price volatile compared to industry and market?SPMA volatilitySPMA Average Weekly Movement4.7%Forestry Industry Average Movement6.7%Market Average Movement8.0%10% most volatile stocks in ID Market15.5%10% least volatile stocks in ID Market3.9%安定した株価: SPMA 、 ID市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: SPMAの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1976833Edward Sopananwww.ptsuparmatbk.comPT Suparma Tbk はインドネシアで紙および関連紙製品を製造・販売している。同社の紙製品には、ラミネート加工された包装紙や茶色のクラフト紙、白色紙、リブ加工されたクラフト再生紙、カートン紙などがある。また、バスティッシュ、フェイシャルティッシュ、ナプキン、キャリーティッシュも提供している。さらに、ハンドタオル、ハンドロール、産業用ロール、臨床用ロール、キッチンタオルも提供している。PT Suparma Tbkは製品を輸出している。同社は以前PT Supar Inpamaとして知られ、1978年12月にPT Suparma Tbkに社名を変更した。PT Suparma Tbkは1976年に設立され、インドネシアのスラバヤに本社を置く。もっと見るPT Suparma Tbk 基礎のまとめSuparma の収益と売上を時価総額と比較するとどうか。SPMA 基礎統計学時価総額Rp869.27b収益（TTM）Rp103.29b売上高(TTM)Rp2.76t8.3xPER（株価収益率0.3xP/SレシオSPMA は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計SPMA 損益計算書（TTM）収益Rp2.76t売上原価Rp2.34t売上総利益Rp416.03bその他の費用Rp312.75b収益Rp103.29b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）25.19グロス・マージン15.09%純利益率3.75%有利子負債／自己資本比率26.0%SPMA の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 12:49終値2026/05/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PT Suparma Tbk 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 23PT Suparma Tbk, Annual General Meeting, Jun 30, 2026PT Suparma Tbk, Annual General Meeting, Jun 30, 2026.
Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).
Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.
お知らせ • May 23PT Suparma Tbk, Annual General Meeting, Jun 30, 2026PT Suparma Tbk, Annual General Meeting, Jun 30, 2026.
Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).
Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023)Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Reported Earnings • Jul 31Second quarter 2024 earnings released: EPS: Rp8.89 (vs Rp12.20 in 2Q 2023)Second quarter 2024 results: EPS: Rp8.89 (down from Rp12.20 in 2Q 2023). Revenue: Rp618.2b (up 2.5% from 2Q 2023). Net income: Rp26.4b (down 31% from 2Q 2023). Profit margin: 4.3% (down from 6.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
New Risk • Jul 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.6% net profit margin). Market cap is less than US$100m (Rp908.4b market cap, or US$55.4m).
お知らせ • May 09PT Suparma Tbk, Annual General Meeting, Jun 14, 2024PT Suparma Tbk, Annual General Meeting, Jun 14, 2024. Location: Vasa Hotel Surabaya Jawa Timur Indonesia
Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp7.00 (vs Rp25.65 in 1Q 2023)First quarter 2024 results: EPS: Rp7.00 (down from Rp25.65 in 1Q 2023). Revenue: Rp657.6b (down 5.9% from 1Q 2023). Net income: Rp22.6b (down 72% from 1Q 2023). Profit margin: 3.4% (down from 12% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 7% per year.
New Risk • Apr 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.7% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.7% net profit margin). Market cap is less than US$100m (Rp1.09t market cap, or US$68.4m).
Reported Earnings • Apr 03Full year 2023 earnings released: EPS: Rp57.00 (vs Rp107 in FY 2022)Full year 2023 results: EPS: Rp57.00 (down from Rp107 in FY 2022). Revenue: Rp2.66t (down 15% from FY 2022). Net income: Rp178.7b (down 47% from FY 2022). Profit margin: 6.7% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year.
Valuation Update With 7 Day Price Move • Oct 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to Rp338, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 4x in the Forestry industry in Indonesia. Total returns to shareholders of 85% over the past three years.
Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: Rp12.30 (vs Rp10.32 in 2Q 2022)Second quarter 2023 results: EPS: Rp12.30 (up from Rp10.32 in 2Q 2022). Revenue: Rp603.0b (down 23% from 2Q 2022). Net income: Rp38.5b (up 4.8% from 2Q 2022). Profit margin: 6.4% (up from 4.7% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 19PT Suparma Tbk, Annual General Meeting, Jun 08, 2023PT Suparma Tbk, Annual General Meeting, Jun 08, 2023, at 03:00 Coordinated Universal Time. Location: Meeting Room of PT Suparma Tbk Jl. Mastrip No. 856 Surabaya Indonesia Agenda: To consider the approval on the company's annual report including the company's audited financial statements and the board of commissioners' Supervisory Duty Report for financial year ended on December 31, 2022; to consider to determine the use of the company's net profit for the financial year ended on December 31, 2022; to consider to appoint the Registered Public Accountant and/or Registered Public Accounting Firm that will Audit the company's financial statements for the financial year ended on December 31, 2023; and to transact such other business issues.
Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Corporate Secretary & Independent Director Hendro Luhur is the most experienced director on the board, commencing their role in 1998. Independent Commissioner M. Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Nov 06Third quarter 2022 earnings released: EPS: Rp54.76 (vs Rp72.09 in 3Q 2021)Third quarter 2022 results: EPS: Rp54.76. Revenue: Rp814.9b (up 15% from 3Q 2021). Net income: Rp130.9b (up 12% from 3Q 2021). Profit margin: 16% (in line with 3Q 2021).
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp555, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 15x in the Forestry industry in Indonesia. Total returns to shareholders of 145% over the past three years.
Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp755, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 19x in the Forestry industry in Indonesia. Total returns to shareholders of 266% over the past three years.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Commissioner Tan Juanto was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp815, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 325% over the past three years.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp685, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 247% over the past three years.
Valuation Update With 7 Day Price Move • Nov 24Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp585, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 213% over the past three years.
Reported Earnings • Nov 07Third quarter 2021 earnings released: EPS Rp79.47 (vs Rp7.85 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp710.0b (up 30% from 3Q 2020). Net income: Rp117.1b (up 435% from 3Q 2020). Profit margin: 17% (up from 4.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to Rp422, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 131% over the past three years.
Reported Earnings • Jul 30Second quarter 2021 earnings released: EPS Rp24.89 (vs Rp30.91 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: Rp616.9b (up 43% from 2Q 2020). Net income: Rp37.7b (down 56% from 2Q 2020). Profit margin: 6.1% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 27% per year.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp390, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 112% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp610, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 123% over the past three years.
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to Rp520, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 12x in the Forestry industry in Indonesia. Total returns to shareholders of 82% over the past three years.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp370, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 24% over the past three years.
Is New 90 Day High Low • Feb 26New 90-day high: Rp336The company is up 3.0% from its price of Rp326 on 27 November 2020. The Indonesian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 62% over the same period.
Is New 90 Day High Low • Jan 28New 90-day low: Rp276The company is down 1.0% from its price of Rp280 on 27 October 2020. The Indonesian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 61% over the same period.
Is New 90 Day High Low • Nov 11New 90-day high: Rp296The company is up 15% from its price of Rp258 on 13 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 1.0% over the same period.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of Rp118.1b, down 19% from the prior year. Total revenue was Rp2.18t over the last 12 months, down 15% from the prior year.
